Sarepta Therapeutics (SRPT) Prepaid Assets (2010 - 2026)
Sarepta Therapeutics' (SRPT) quarterly Prepaid Assets came in at $2.2 million in Q1 2026, down 97.9% year-on-year from $105.5 million in Q1 2025, and down 98.71% quarter-over-quarter from $171.9 million in Q4 2025.
Sarepta Therapeutics (SRPT) Prepaid Assets (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 97.9% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 97.9% decrease from a year earlier, with the FY2025 full-year figure at $171.9 million, up 89.98% from the prior year.
- Prepaid Assets slipped to $2.2 million in Q1 2026 per SRPT's latest filing, from $171.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $179.8 million in Q1 2023 and bottomed at $2.0 million in Q1 2024.
- The 5-year median for Prepaid Assets is $105.5 million (2025), against an average of $88.7 million.
- Across the five-year window, Prepaid Assets soared 12605.93% in 2022 and sank 98.91% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $149.9 million in 2022, then tumbled by 97.76% to $3.4 million in 2023, then soared by 2598.72% to $90.5 million in 2024, then soared by 89.98% to $171.9 million in 2025, then sank by 98.71% to $2.2 million in 2026.
- Per Business Quant, the three latest SRPT Prepaid Assets figures stand at $2.2 million (Q1 2026), $171.9 million (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 171.86 Mn |
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 127.59 Mn |
| Mar 31, 2025 | 105.48 Mn |
| Dec 31, 2024 | 90.46 Mn |
| Sep 30, 2024 | 165.48 Mn |
| Jun 30, 2024 | 74.74 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | 154.44 Mn |
| Jun 30, 2023 | 3.14 Mn |
| Mar 31, 2023 | 179.77 Mn |
| Dec 31, 2022 | 149.89 Mn |
| Sep 30, 2022 | 130.74 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 140.33 Mn |
| Dec 31, 2021 | 149.03 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 894,000.00 |